|** The 2020 AhR Symposium has been rescheduled for June 2021 – dates and details will be available soon – check back often — Thank You **
Dr. Gary Perdew and Dr. Andrew Patterson along with The Pennsylvania State University are proud to announce the hosting of the 2020 AHR Symposium: Toxicity to Therapeutics. The Symposium will be held June 14 – 18, 2020.
The 2020 AHR Symposium will bring together world-renowned scientists in an integrated program to discuss the latest knowledge on the role of the aromatic hydrocarbon receptor (AHR) in a wide range of fields, from basic immunology to cancer immunotherapy. AHR is recognized as a transcription factor activated by many pollutants, responsible for the induction of xenobiotic metabolism enzymes and receptor hyperactivation can lead to toxic outcomes, such as tumor promotion.
More recently, other functions of this enigmatic receptor have been described (immune responses, barrier function, gastrointestinal homeostasis, hormonal signaling, cell cycle progression, oxidative stress, inflammation, differentiation, development, and apoptosis). An ever-expanding list of endogenous and exogenous AHR ligands continue to be identified and their biological relevance determined. It is evident that the AHR, is a key environmental/physiological sensor, which integrates numerous biological and pathophysiological processes and is now considered a viable drug target.
The venue of the conference will be held at The Pennsylvania State University in State College, PA and will provide a unique environment for all those who wish to foster/develop collaborative projects and expand their understanding of the complexities of AHR biology.
Symposium information can be found at http://www.cvent.com/events/ahr-symposium-2020/event-summary-2be462a66546473e8081577adb507883.aspx